Chen Xiao-chao, Xu Ming-tong, Zhou Wu, Han Chun-li, Chen Wei-qing
Department of Cardiology, Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, Guangdong Province, China.
Chin Med J (Engl). 2007 Jul 5;120(13):1198-202.
The results of studies on association between -148C/T polymorphism in promoter region of beta-fibrinogen gene and susceptibility to cerebral infarction in Chinese population are controversial. In this study, we summarize the results of published works in this field by a meta-analysis. Data sources Genetic association studies evaluating the beta-fibrinogen gene -148C/T polymorphisms and cerebral infarction involving Chinese population published before December 2005 were collected from PubMed, EMBASE and CNKI. Study selection Case control studies involving unrelated, Han subjects aged from 18 to 80 years, and the internationally recognized diagnostic standard of cerebral infarction and genotype frequencies in control group consistent with Hardy-Weinberg equilibrium were used. Publication bias was tested by funnel plot and the odds ratios of all studies were combined dependent on the result of heterogeneity test among the individual studies. The software Review Manager (Version 4.2) was used for meta-analysis.
Eleven studies including 1223 patients and 1433 controls met the selection criteria. There was no heterogeneity among the odds ratios (ORs) of individual studies (chi(2) = 17.82, P = 0.06). The combined OR of susceptibility to cerebral infarction in -148T allele carriers compared to the wild homozygote was 1.32 (95% CI 1.12 to 1.55, P = 0.0008). In the patients with cerebral infarction, the average plasma fibrinogen level of allele T carrier was 0.42 g/L (95% CI 0.29 to 0.54, P < 0.001), higher than that of -148C/C homozygous ones.
beta-fibrinogen gene -148C/T polymorphism might contribute to susceptibility to cerebral infarction in Han Chinese. To reach a definitive conclusion, further gene to gene and gene to environment interactions studies on beta-fibrinogen polymorphisms and cerebral infarction with large sample size are required.
关于β-纤维蛋白原基因启动子区-148C/T多态性与中国人群脑梗死易感性之间关联的研究结果存在争议。在本研究中,我们通过荟萃分析总结该领域已发表研究的结果。
从PubMed、EMBASE和CNKI收集2005年12月之前发表的评估β-纤维蛋白原基因-148C/T多态性与中国人群脑梗死的遗传关联研究。
采用病例对照研究,研究对象为年龄在18至80岁之间的非亲属汉族受试者,采用国际公认的脑梗死诊断标准,且对照组的基因型频率符合Hardy-Weinberg平衡。通过漏斗图检验发表偏倚,并根据各研究间异质性检验结果合并所有研究的比值比。使用Review Manager软件(版本4.2)进行荟萃分析。
11项研究(包括1223例患者和1433例对照)符合入选标准。各研究的比值比(OR)之间不存在异质性(χ² = 17.82,P = 0.06)。与野生纯合子相比,-148T等位基因携带者发生脑梗死的合并OR为1.32(95%可信区间1.12至1.55,P = 0.0008)。在脑梗死患者中,等位基因T携带者的平均血浆纤维蛋白原水平为0.42 g/L(95%可信区间0.29至0.54,P < 0.001),高于-148C/C纯合子。
β-纤维蛋白原基因-148C/T多态性可能与汉族人群脑梗死易感性有关。为得出明确结论,则需要进一步开展大样本量的β-纤维蛋白原多态性与脑梗死的基因间及基因与环境相互作用研究。